John Quisel Insider Profile
4 Followers
John Quisel, Director at Gossamer Bio, holds ― shares in Gossamer Bio (Ticker: GOSS), holds 262.06K shares in Disc Medicine (Ticker: IRON), holds 53.32K shares in Acceleron Pharma (Ticker: XLRN). Most recently, John Quisel ― shares of Gossamer Bio on ― for an estimated value of ―.
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+5.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Quisel holds in companies
Most Profitable Insider Trade
Stock:
Acceleron Pharma
(XLRN)
(XLRN)
Rating:Informative Buy
Date:Aug 03, 2015 - Aug 03, 2016
Return:+17.70%
The most profitable trade made by John Quisel
John Quisel's Trading History
Gossamer Bio
―
Director
―
―
Acceleron Pharma
Jan 03, 2020
―
Uninformative Sell
306.81K
$9.53M
Disc Medicine
Sep 16, 2026
CEO, Director
Uninformative Buy
36.36K
$17.26M
List of latest transactions for each holding click on a transaction to see John Quisel's performance on stock
You May Also Like
John Quisel insider profile FAQ
What is the percentage of profitable transactions made by John Quisel?
The percentage of profitable transactions made by John Quisel is 80%.
What is the average return per transaction made by John Quisel?
The average return per transaction made by John Quisel is 5.50%.
What stocks does John Quisel hold?
John Quisel holds: GOSS, XLRN, IRON stocks.
What was John Quisel’s latest transaction?
John Quisel latest transaction was an Uninformative Buy of ―.
What was John Quisel's most profitable transaction?
John Quisel’s most profitable transaction was an Informative Buy of XLRN stock on August 3, 2015. The return on the trade was 17.70%.
What is John Quisel's role in Gossamer Bio?
John Quisel's role in Gossamer Bio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.